Furthermore, the reverse correlation between PRMT1 expression and CTL infiltration also occurred in other cancer types, including acute myeloid leukemia (AML), ovarian cancer (OVCA), lung cancer (LUCA), bladder cancer (BLCA), liver cancer, and diffuse large B cell lymphoma (DLBC, Supplementary Fig. 4h–o), supporting the notion that PRMT1 acts as a suppressor of tumor immune surveillance. This evidence concerns the gene PRMT1 and ovarian carcinoma.